Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel

Emanuele Angelucci, Susanne Matthes-Martin, Donatella Baronciani, Françoise Bernaudin, Sonia Bonanomi, Maria Domenica Cappellini, Jean Hugues Dalle, Paolo Di Bartolomeo, Cristina Díaz de Heredia, Roswitha Dickerhoff, Claudio Giardini, Eliane Gluckman, Ayad Achmed Hussein, Naynesh Kamani, Milen Minkov, Franco Locatelli, Vanderson Rocha, Petr Sedlacek, Frans Smiers, Isabelle ThuretIsaac Yaniv, Marina Cavazzana, Christina Peters

Research output: Contribution to journalArticlepeer-review

Abstract

Thalassemia major and sickle cell disease are the two most widely disseminated hereditary hemoglobinopathies in the world. The outlook for affected individuals has improved in recent years due to advances in medical management in the prevention and treatment of complications. However, hematopoietic stem cell transplantation is still the only available curative option. The use of hematopoietic stem cell transplantation has been increasing, and outcomes today have substantially improved compared with the past three decades. Current experience world-wide is that more than 90% of patients now survive hematopoietic stem cell transplantation and disease-free survival is around 80%. However, only a few controlled trials have been reported, and decisions on patient selection for hematopoietic stem cell transplantation and transplant management remain principally dependent on data from retrospective analyses and on the clinical experience of the transplant centers. This consensus document from the European Blood and Marrow Transplantation Inborn Error Working Party and the Paediatric Diseases Working Party aims to report new data and provide consensus-based recommendations on indications for hematopoietic stem cell transplantation and transplant management.

Original languageEnglish
Pages (from-to)811-820
Number of pages10
JournalHaematologica
Volume99
Issue number5
DOIs
StatePublished - 1 May 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel'. Together they form a unique fingerprint.

Cite this